If hormone therapy is not an option for you — or simply not what you want — the honest news is that the alternatives are better than they were five years ago. There are now prescription medications developed specifically for hot flashes that contain no hormones at all, alongside several older drugs with real evidence. Here is what exists, how well each works, and what to ask for.

Where we stand: Menova is an independent publication. We sell no medication and take no payment from any manufacturer. We are not your doctor, and this is general education, not medical advice or a recommendation of any drug.

Who this is for

  • Women with a history of breast cancer or other hormone-sensitive cancer; see managing menopause after breast cancer
  • Women with a history of blood clots, stroke, or certain cardiovascular conditions
  • Women with severe liver disease or other contraindications
  • Women who have tried hormone therapy and did not tolerate it
  • Women who, having read the risks and benefits, simply prefer not to take hormones — a complete reason on its own

The newer class: NK3 receptor antagonists

This is the genuine development. Researchers identified that hot flashes involve a specific group of neurons in the hypothalamus — the KNDy neurons — which become overactive when estrogen falls and disrupt the brain's temperature control. Neurokinin receptor antagonists block that signalling directly.

Fezolinetant (brand name Veozah) was approved by the FDA in 2023 for moderate to severe vasomotor symptoms due to menopause. Elinzanetant is a related drug that has since progressed through approval processes in several markets.

What matters about them:

  • They are not hormones, so the estrogen-related considerations do not apply
  • Trials show meaningful reductions in both the frequency and severity of hot flashes, with effects beginning within weeks
  • Liver monitoring is required with fezolinetant — the FDA has strengthened warnings regarding rare liver injury, and blood tests before starting and periodically afterward are part of the treatment
  • Common side effects include abdominal pain, diarrhoea, insomnia, and back pain
  • Cost and coverage are the practical barrier. These are expensive relative to older options, and insurance coverage varies considerably

Ask about them by name. Many clinicians outside menopause specialty practice are not yet routinely offering them.

The established options

Certain antidepressants (SSRIs and SNRIs) at low doses reduce hot flashes, and this is not a case of treating you for depression by proxy — the doses used are often lower and the effect on vasomotor symptoms is separate. A low-dose form of paroxetine is FDA-approved specifically for hot flashes; venlafaxine, escitalopram, and citalopram are used off-label with reasonable evidence.

One important detail: if you take tamoxifen, avoid paroxetine and fluoxetine, which inhibit the enzyme that activates it. Venlafaxine is commonly preferred in that situation. Raise this explicitly.

Gabapentin has good evidence, particularly where night sweats dominate, because the sedative effect is useful at bedtime. Drowsiness and dizziness are the main limits.

Oxybutynin reduces hot flashes with modest evidence. Anticholinergic effects — dry mouth, constipation, and cognitive effects in older women — are the consideration.

Clonidine, a blood pressure medication, has been used for decades with modest benefit and side effects including dry mouth and low blood pressure. Generally considered less effective than the options above.

What to expect, honestly

Non-hormonal options generally reduce hot flashes less than hormone therapy does. That is the trade-off, and any source claiming equivalence is overselling.

What that means in practice: a meaningful reduction in frequency and severity for many women — enough to sleep through the night, enough to sit through a meeting — rather than elimination. For someone who cannot take hormones, that difference is substantial.

Give any of them four to eight weeks before judging, and treat the first one as an experiment rather than a verdict. Switching because something did not suit you is normal.

What these do not treat

Worth being clear, because it changes what else you need:

  • Vaginal and urinary symptoms are not addressed by any of these. These progress without treatment, and local vaginal estrogen or non-estrogen prescription options are a separate conversation — see GSM and urinary changes and is vaginal estrogen safe.
  • Bone protection. Hormone therapy reduces fracture risk; these do not. If bone is a concern, that needs its own plan — see bone health in menopause.
  • Joint pain, brain fog, and mood are not directly targeted, though sleeping better helps all three.

Non-drug options with real evidence

Worth combining rather than choosing between:

  • CBT has evidence for reducing how much hot flashes interfere with life, even when frequency changes less. Digital programmes are widely available.
  • Clinical hypnosis has supporting trial evidence for vasomotor symptoms and is under-used.
  • Weight loss, where relevant, is associated with reduced vasomotor symptoms.
  • Stopping smoking, which is associated with more severe hot flashes.
  • Trigger management — alcohol, spicy food, caffeine, and heat — which is individual and worth testing properly; see hot flash triggers and relief and night sweats.

What has weak evidence

Most supplements marketed for hot flashes, including black cohosh, evening primrose oil, and "menopause support" blends. Some phytoestrogen products have modest evidence at best, and — importantly — anything with estrogenic activity needs checking with your oncology team if you have had a hormone-sensitive cancer. Our review is at what the supplement research actually says.

How to ask

Be specific, because these are not always offered:

"Hormone therapy isn't an option for me. I'd like to discuss non-hormonal prescription treatments for my hot flashes — including whether fezolinetant would be appropriate, and if not, whether venlafaxine or gabapentin would suit my situation."

Naming the options changes the conversation. If your clinician is not familiar with the newer class, that is a reason to ask for a referral rather than to accept that nothing exists — our guide to finding a clinician who knows menopause covers how.

Bring a record. "Fourteen hot flashes a day and waking four times a night" makes the case that "I'm struggling" does not — the free 30-day symptom tracker and free printable visit prep sheet exist for exactly that.

The free 2-minute Menova self-check organizes your wider symptom picture — no account, not a diagnosis, and your answers never leave your device.

This article is general education, not medical advice and not a recommendation of any medication. All of these are prescription drugs with side effects, contraindications, and in some cases monitoring requirements. Decide with a licensed clinician who knows your full history.

Sources: FDA — Drug Approvals and Safety Communications, The Menopause Society, ACOG, and NICE NG23.